carbohydr
tradit
consid
bioenergi
supplier
structur
compon
found
wide
varieti
biolog
physiolog
function
therefor
togeth
protein
peptid
nucleic
acid
oligonucleotid
lipid
carbohydr
consid
one
import
class
biomacromolecul
addit
relationship
among
four
class
biomolecul
often
intertwin
exampl
protein
glycosyl
import
conform
transport
function
fate
glycosyl
lipid
glycolipid
essenti
biomolecul
nucleic
acid
glycosyl
whether
synthet
natur
recent
recogn
import
affect
distribut
function
properti
surpris
carbohydr
biomark
cell
type
diseas
state
protein
function
development
state
recent
year
seen
rapid
increas
knowledg
relat
area
mention
advanc
larg
attribut
develop
new
techniqu
nmr
mass
spectrometri
molecular
biolog
readi
avail
genom
inform
result
recent
advanc
glycobiolog
glycom
also
open
new
door
develop
new
therapeut
imag
agent
carbohydr
recognit
therefor
compound
specif
recogn
particular
carbohydr
import
applic
use
sensor
detect
diagnosi
prognosi
blockersinhibitor
therapeut
develop
target
carbohydr
involv
pathogenesi
vector
target
deliveri
imag
therapeut
agent
critic
potenti
applic
two
issu
identif
carbohydr
biomark
design
synthesi
binder
specif
recogn
target
biomark
high
affin
specif
review
present
select
exampl
import
carbohydr
biomark
target
develop
therapeut
diagnost
agent
note
mani
book
glycobiolog
mani
review
articl
one
target
carbohydr
variou
applic
would
imposs
cover
entir
topic
detail
therefor
articl
strive
comprehens
instead
meant
tutori
hope
would
help
gener
interest
carbohydr
recognit
way
develop
new
therapeut
diagnost
carbohydr
recognit
research
impact
essenti
area
carbohydr
play
role
exampl
includ
infecti
diseas
cancer
inflamm
immun
respons
signal
transduct
stem
cell
transform
embryo
develop
cardiovascular
diseas
follow
section
divid
discuss
base
diseas
categori
though
issu
cross
therapeut
boundari
last
section
present
simpl
exampl
target
carbohydr
biomark
diagnost
therapeut
applic
among
patholog
relev
glycosyl
chang
cancer
probabl
extens
studi
even
normal
cell
surfac
carbohydr
structur
known
characterist
marker
differ
type
cell
transform
normal
cancer
cell
often
associ
alter
cell
surfac
carbohydr
express
overexpress
certain
carbohydr
close
correl
cancer
therefor
mani
carbohydr
consid
cancer
associ
antigen
caa
among
carbohydratebas
caa
globo
h
tn
antigen
probabl
common
known
tn
antigen
found
cell
surfac
solid
tumor
format
tn
antigen
defici
enzym
name
result
incomplet
convers
tn
antigen
antigen
import
cancerrel
carbohydr
includ
sialyl
carbohydr
exampl
sialyl
lewi
x
sle
x
shown
mediat
lung
colon
melanoma
cell
yet
excess
sle
x
express
shown
lead
reject
natur
killer
cell
serum
sle
x
cytokeratin
fragment
said
predict
factor
recurr
patient
stage
nonsmal
cell
lung
cancer
sle
x
sialyl
lewi
sle
shown
mediat
adhes
urotheli
cancer
cell
activ
endothelium
chang
sle
x
sle
level
cancer
attribut
neosynthesi
incomplet
synthesi
pathway
involv
sulfat
sialyl
variat
enzym
level
directli
correl
certain
chang
glycosyl
aberr
glycan
express
binder
recogn
carbohydr
use
research
tool
diagnost
agent
possibl
therapeut
agent
addit
cell
surfac
carbohydr
biomark
postcotransl
protein
glycosyl
often
carri
signatur
malign
transform
term
biolog
signific
protein
glycosyl
usual
question
whether
glycosyl
rather
glycosyl
pattern
mark
differ
patholog
state
includ
malign
exampl
glycosyl
pattern
prostat
specif
antigen
psa
cancer
cell
cultur
prostat
cancer
patient
tissu
sera
differ
normal
prostat
human
pancreat
rnase
glycoprotein
secret
mostli
pancreat
cell
complet
differ
oligosaccharid
chain
produc
pancreat
tumor
cell
pregnancyrel
human
chorion
gonadotropin
hcg
biomark
cancer
syndrom
pregnanc
failur
depend
glycosyl
pattern
specif
glycosyl
pattern
haptoglobin
hp
alphafetoprotein
afp
much
higher
degre
correl
cancer
total
hpafp
level
case
binder
recogn
glycosyl
variat
use
diagnost
tool
sever
way
carbohydr
involv
pathogen
infecti
agent
case
viral
infect
human
influenza
viru
excel
exampl
flu
viral
infect
involv
sialic
acid
bind
hemagglutinin
infect
infect
bud
matur
virus
infect
cell
involv
cleavag
sialic
acid
neuraminidas
order
viru
detach
flu
drug
tamiflu
function
inhibit
neuraminidas
thu
inhibit
viral
replic
case
human
immunodefici
viru
hiv
critic
protein
glycosyl
polymannos
infect
cell
requir
fusion
viral
membran
cellular
membran
fusion
mediat
along
cell
surfac
receptor
chemokin
receptor
target
cell
conceiv
agent
interact
may
interfer
viral
entri
target
cell
bind
glycan
viral
envelop
may
also
forc
viru
delet
portion
glycan
shield
make
viru
suscept
attack
along
line
sever
lectin
studi
antihiv
activ
exampl
cyanovirinn
cvn
protein
amino
acid
affin
highmannos
glycan
especi
link
mannos
oligom
cvn
inactiv
tlymphocytetrop
laboratori
strain
hiv
type
hiv
type
well
ttropic
mtropic
dual
tropic
primari
clinic
isol
presum
inhibit
viral
entri
block
part
cemss
cell
cvn
ec
nm
control
treatment
uninfect
cemss
cell
presenc
high
concentr
nm
cvn
attenu
lethal
effect
viru
lectin
also
shown
similar
effect
presum
bind
polymannos
portion
includ
svn
scytovirm
affin
mannos
trisaccharid
unit
inhibit
hiv
infect
ttropic
laboratori
strain
cemss
cell
ec
nm
actinohivin
affin
mannosetyp
glycan
inhibit
tcell
macrophag
infect
cell
cultur
ic
nm
result
indic
viral
envelop
glycan
play
import
role
pathogen
bacteri
pathogen
carbohydr
also
play
import
role
one
promin
exampl
lipopolysaccharid
lp
also
known
endotoxin
outer
membran
cell
wall
gram
neg
bacteria
one
exampl
pasteurella
multocida
encapsul
gramneg
coccobacillu
caus
wide
rang
anim
diseas
includ
avian
fowl
cholera
infect
gramneg
bacteria
occur
lp
stimul
immun
system
attempt
clear
bacteria
infect
may
result
lipid
compon
lp
primarili
respons
inflammatori
respons
infect
proce
presenc
larg
amount
lp
result
overproduct
inflammatori
mediat
result
damag
tissu
septic
shock
organ
failur
death
lp
also
shown
play
import
role
pathogenesi
p
multocida
modif
lp
structur
neg
affect
viabil
p
multocida
vivo
addit
function
toxin
carbohydr
also
target
bacteri
recognit
exampl
mani
pulmonari
pathogen
bacteria
bind
specif
carbohydr
sequenc
galnac
beta
found
glycolipid
pseudomona
aeruginosa
pseudomona
cepacia
isol
cystic
fibrosi
patient
bind
specif
gangliotetraosylceramid
asialo
gangliotriaosylceramid
asialo
pili
p
aeruginosa
strain
pak
pao
bind
specif
carbohydr
sequenc
beta
galnac
beta
gal
found
glycosphingolipid
adher
p
aeruginosa
candida
albican
glycosphingolipid
receptor
achiev
conserv
receptorbind
domain
present
adhes
lactoand
ganglioseri
glycolipid
adhes
receptor
neisseria
gonorrhoea
mani
exampl
addit
serotyp
gramneg
bacteria
primarili
base
lp
structur
mani
way
carbohydr
affect
bacteria
fungi
infect
one
envis
situat
artifici
binder
target
carbohydr
use
detect
treatment
bacteri
fungal
infect
carbohydr
involv
mediat
inflammatori
process
mani
way
wide
known
exampl
probabl
sle
x
mediat
white
blood
cell
adhes
infectiondamag
site
interact
lselectin
recent
studi
unveil
glcnac
sulfat
modif
sle
x
tetrasaccharid
import
lselectin
activ
anim
leukocyt
invas
differ
human
tissu
furthermor
de
novo
induct
endotheli
sle
x
sulfat
form
interact
lselectin
common
event
mani
organ
includ
thyroid
gland
heart
skin
colon
thu
suggest
crucial
role
glycan
earlyst
induct
tissu
inflamm
promin
exampl
carbohydratemedi
immun
respons
origin
abo
blood
group
antigen
entir
carbohydratebas
figur
show
structur
antigen
differ
b
blood
type
due
termin
galactosamin
nacetyl
red
blood
cell
type
antigen
lack
termin
sugar
therefor
person
one
blood
type
would
natur
antibodi
type
b
target
differ
termin
sugar
structur
howev
sinc
otyp
antigen
termin
sugar
common
sugar
structur
antibodi
common
core
produc
individu
blood
type
reason
otyp
univers
anoth
type
carbohydratemedi
immun
respons
natur
immun
human
anim
tissu
exampl
pig
cell
surfac
antigen
includ
moieti
absent
human
cell
therefor
human
natur
antibodi
acut
immun
respons
major
hurdl
organ
transplant
use
pig
organ
year
ago
genet
engin
pig
produc
lack
moieti
thu
allow
organ
transplant
use
pig
organ
move
one
step
closer
realiti
addit
target
deliveri
moieti
also
use
elicit
immun
respons
specif
locat
cell
type
fundament
stem
cell
differenti
embryo
develop
process
transform
pluripot
stem
cell
special
function
mark
differ
stage
characterist
stagespecif
biomark
biomark
often
carbohydratebas
target
binder
develop
variou
applic
exampl
lewi
x
le
x
identifi
stagespecif
embryon
antigen
use
identifi
isol
specif
cell
type
heterogen
popul
along
line
report
sort
svz
cell
basi
le
x
good
strategi
enrich
restrict
highli
prolif
neutral
stem
cell
popul
exampl
carbohydr
chang
variou
development
stage
includ
enrich
fucos
incorpor
macromolecul
found
cell
surfac
stage
preimplant
mous
embryo
sialic
acid
found
day
incub
metanephro
time
nacetyldglucosamin
alphadmannos
found
exist
ubiquit
chick
embryo
develop
glycopeptid
found
mainli
nlink
oand
nlink
day
increas
sialyl
small
glycopeptid
content
glycosyl
two
ident
polypeptid
chain
found
organ
specif
analysi
chicken
serum
transferrin
ovotransferrin
glycan
also
mani
exampl
biomark
tumor
reject
antigen
tra
result
indic
carbohydr
biomark
play
import
role
stem
cell
differenti
embryo
develop
stem
cell
research
one
critic
element
abil
purifi
cell
differenti
stage
lineag
binder
recogn
stagespecif
biomark
use
purpos
separ
identif
along
line
aptam
use
sinc
select
requir
prior
knowledg
natur
structur
biomark
question
success
exampl
select
aptam
cellsurfac
biomark
use
whole
cell
select
exampl
liver
cancerspecif
aptam
develop
use
whole
live
cell
studi
demonstr
cellbas
aptam
select
specif
recogn
cell
multipl
cell
line
even
two
cell
line
minor
differ
anoth
studi
seri
aptam
select
leukemia
cell
aptam
dissoci
constant
k
nano
picomolar
rang
select
aptam
could
specif
recogn
leukemia
cell
mix
normal
human
bone
marrow
aspir
aptam
also
use
identifi
cancer
cell
close
relat
target
cell
line
real
clinic
specimen
therefor
cellbas
select
promis
method
develop
specif
molecular
probe
cellsurfac
biomark
recognit
similar
approach
appli
stem
cell
select
aptam
capabl
recogn
stagespecif
carbohydr
biomark
recent
develop
boron
acidmodifi
dnabas
aptam
allow
select
high
affin
binder
glycoprotein
abil
differenti
variat
glycosyl
pattern
tremend
enhanc
chanc
find
high
affin
aptam
cellsurfac
carbohydr
biomark
intrins
affin
boron
acid
moieti
carbohydr
recent
schultz
lab
develop
way
engin
boron
acidmodifi
protein
also
use
select
artifici
lectin
carbohydr
recognit
signal
transduct
area
promin
exampl
probabl
glycosphingolipid
gsl
involv
whole
host
activ
gsl
gener
structur
two
hydrophob
tail
ceramid
consist
sph
fatti
acid
one
carbohydr
chain
orient
perpendicularli
gsl
held
membran
ceramid
carbohydr
chain
access
variou
ligand
antibodi
lectin
complementari
carbohydr
figur
gsl
integr
part
cellular
membran
function
antigen
receptor
microbi
toxin
mediat
cell
adhes
modul
signal
transduct
mani
function
attribut
uniqu
properti
gsl
form
cluster
glycosynaps
refer
glycosphingolipidsenrich
microdomain
glycosynapt
domain
control
gsldepend
modul
cell
adhes
growth
motil
form
interact
gsl
cluster
function
membran
protein
modul
glycosynaps
function
lead
new
strategi
cancer
therapi
elucid
molecular
mechan
interact
among
compon
glycosynapt
domain
might
shed
light
new
possibl
approach
disrupt
promot
interact
protein
glycosyl
known
involv
regul
signal
transduct
well
exampl
dynam
glycosyl
serin
threonin
residu
nuclear
cytosol
protein
olink
oglcnac
implic
regul
proteinprotein
interact
andor
protein
function
notch
signal
pathway
could
regul
alter
ofucos
structur
ofucos
modif
cripto
essenti
nodaldepend
signal
glycosyl
human
crlr
requir
ligand
bind
signal
elev
nucleocytoplasm
glycosyl
oglcnac
result
insulin
resist
associ
defect
akt
activ
altern
oglycosylationophosphoryl
regul
activ
murin
estrogen
receptor
beta
nfkappab
activ
associ
oglcnacyl
state
hyperglycem
condit
glucos
depriv
stimul
oglcnac
modif
protein
upregul
olink
nacetylglucosaminyltransferas
mitot
glcnacylationphosphoryl
signal
complex
alter
posttransl
state
cytoskelet
protein
vimentin
oglycosyl
insulin
seem
enhanc
nuclear
recruit
result
activ
cam
gene
transcript
glycosyl
guanylyl
cyclas
c
affect
conform
function
abil
mani
report
similar
natur
uniqu
glycosyl
base
also
call
base
j
identifi
nuclear
dna
trypanosoma
brucei
rare
case
dna
glycosyl
known
play
import
physiolog
role
signal
transduct
gene
silenc
specif
base
j
said
first
hypermodifi
base
found
eukaryot
dna
telomer
repeat
present
kinetoplastid
flagel
analyz
unicellular
flagel
close
relat
trypanosomatid
one
studi
sabatini
cowork
propos
model
chromatin
remodel
j
bind
protein
regul
initi
site
j
synthesi
within
bloodstream
form
trypanosom
dna
propag
mainten
j
synthesi
j
within
telomer
dna
trypanosoma
brucei
correl
bloodstreamformspecif
epigenet
silenc
telomer
variant
surfac
glycoprotein
gene
involv
antigen
variat
result
suggest
bind
modul
glycan
variou
protein
lipid
even
dna
may
allow
regul
signal
transduct
cardiovascular
area
case
glycosyl
hemoglobin
technic
glycat
sinc
attach
sugar
moieti
chemic
reaction
wide
recogn
specif
glycat
hemoglobin
glchb
level
strong
indic
cardiovascular
diseas
cvd
risk
diabet
patient
die
cvd
rate
time
higher
without
diabet
vivo
glycat
normal
defin
nonenzymat
reaction
glucos
amino
group
protein
form
amadori
product
scheme
gener
consid
first
step
maillard
reaction
later
stage
maillard
reaction
lead
format
sugarderiv
protein
adduct
advanc
glycat
endproduct
age
play
import
role
pathogenesi
chronic
diseas
term
glchb
gener
refer
full
spectrum
glycat
hemoglobin
includ
contain
glycat
valin
hba
andor
lysin
residu
normoglycem
person
glchb
account
total
hemoglobin
end
erythrocyt
lifespan
day
includ
hba
howev
elev
glucos
concentr
diabet
patient
significantli
increas
glycat
reaction
exampl
diabet
patient
fold
increas
hba
although
certain
import
question
regard
prevent
cvd
diabet
patient
remain
unresolv
epidemiolog
analys
suggest
increas
glycat
hemoglobin
elev
risk
cvd
approxim
anoth
exampl
glycosyl
effect
cardiovascular
diseas
fibrinogen
circul
blood
precursor
fibrin
structur
compon
blood
clot
play
key
role
platelet
aggreg
final
step
coagul
cascad
major
deterschem
reaction
glucos
amino
group
protein
form
amadori
product
minant
plasma
viscos
erythrocyt
aggreg
fibrinogen
glycoprotein
molecular
weight
kda
contain
approxim
carbohydr
consist
neuac
gal
man
glcnac
amino
acid
sequenc
studi
determin
carbohydr
link
chain
chain
carbohydr
moieti
play
import
role
fibrinogen
function
involv
clot
process
although
contradictori
result
report
deglycosyl
fibrinogen
could
acceler
polymer
increas
later
aggreg
fibrin
fiber
desialyl
oligosaccharid
chain
fibrinogen
could
potenti
mediat
plasma
clearanc
via
hepat
galactos
galactosamin
bind
lectin
alter
amount
carbohydr
fibrinogen
known
directli
relat
certain
type
dysfibrinogenemia
extra
neg
charg
sialic
acid
fibrinogen
impair
fibrin
polymer
presum
due
repuls
forc
charg
steric
hindranc
present
addit
glycan
structur
also
impair
fibrin
polymer
fibrinogenrel
abnorm
also
implic
diseas
hepatoma
pancreat
cancer
tumor
metastasi
human
hemopoiet
cell
prolifer
embryogenesi
reproduct
patholog
chang
directli
relat
abnorm
glycosyl
addit
mani
situat
glycosyl
affect
health
cardiovascular
system
exampl
certain
congenit
disord
glycosyl
link
intracrani
hemorrhag
exampl
far
complet
list
best
highlight
exampl
glycosyl
variat
play
import
role
determin
biolog
outcom
howev
even
incomplet
list
seen
binder
recogn
carbohydr
biomark
high
specif
affin
would
great
applic
potenti
sensor
concentr
analysi
diagnost
possibl
therapeut
agent
section
describ
gener
concept
artifici
binder
design
note
sever
extens
review
book
chapter
subject
follow
section
far
comprehens
treat
basic
conceptu
descript
reader
refer
publish
review
book
chapter
detail
discuss
binder
recogn
certain
carbohydr
high
affin
specif
use
research
tool
potenti
diagnost
therapeut
agent
howev
achiev
high
affin
high
specif
carbohydr
recognit
trivial
issu
molecular
recognit
antibodi
often
gold
standard
howev
case
carbohydr
rais
antibodi
often
difficult
task
often
low
affin
igm
antibodi
obtain
recent
boon
colleagu
develop
remark
synthet
approach
carbohydrateprotein
conjug
elicit
strong
immun
respons
high
titer
natur
occur
protein
binder
includ
lectin
hundr
lectin
identifi
commerci
readili
avail
lectin
certain
specif
base
overal
topolog
sugar
composit
exampl
lectin
recogn
polymannos
structur
other
recogn
galactos
connect
differ
structur
howev
essenti
lectin
cross
reactiv
issu
recent
year
seen
great
deal
interest
develop
artifici
lectin
variou
applic
artifici
lectin
gener
divid
two
type
boron
acidbas
nonboron
acid
base
reason
boron
acid
play
import
role
form
tight
complex
diolcontain
compound
sometim
singl
hydroxyl
group
interact
suffici
reinforc
highli
specif
macromolecular
interact
aspect
discuss
detail
recent
review
duplic
one
thing
need
emphas
mispercept
boron
acid
interact
linear
diol
diol
fivememb
ring
ampl
literatur
preced
demonstr
boron
acid
interact
singl
hydroxyl
group
nucleophileslewi
base
also
play
import
role
designingselect
carbohydr
binder
sinc
boron
acidcontain
carbohydr
binder
function
similar
fashion
lectin
term
boronolectin
within
boronolectin
categori
small
moleculeand
macromoleculebas
boronolectin
includ
boron
acidbas
carbohydr
sensor
nucleic
acidbas
boronolectin
nabl
peptid
boronolectin
pbl
protein
boronolectin
prbl
categori
discuss
briefli
approach
design
mostli
base
hydrophob
hydrogen
bond
interact
recognit
though
earli
effort
mostli
recognit
organ
solvent
recent
remark
progress
make
noncoval
carbohydr
binder
show
reason
high
affin
water
especi
davi
lab
one
exampl
come
success
design
binder
figur
allequatori
disaccharid
dcellobios
good
affin
select
aqueou
solut
receptor
two
build
block
ametatertphenyl
structur
provid
roof
floor
hydrophob
interact
carbohydr
defin
length
bind
caviti
isophthalamid
unit
serv
pillar
potenti
form
hydrogen
bond
promot
solubl
well
prevent
caviti
collaps
bind
constant
report
select
carbohydr
determin
recent
boon
davi
report
anoth
analog
figur
use
design
concept
biphenyl
roof
floor
well
isophthalamid
pillar
previou
studi
receptor
show
weak
bind
unit
k
glucos
dglucos
k
expand
studi
recent
report
strong
select
receptor
appar
bind
constant
glcnac
figur
receptor
determin
compet
well
one
lectin
wga
k
furthermor
receptor
higher
select
glcnac
nacetylaminosugar
among
carbohydr
sensor
boron
acid
emerg
commonli
use
function
group
recognit
due
strong
interact
diol
aminoalcohol
acid
alcohol
well
cyanid
fluorid
intrins
abil
boron
acid
interact
nucleophil
describ
scheme
boron
atom
valenc
electron
trigon
neutral
form
make
boron
acid
lewi
acid
capabl
strong
interact
lewi
basesnucleophil
result
boron
acid
scheme
group
abl
react
protic
solvent
convert
anion
tetrahedr
form
abl
form
tight
revers
complex
lewi
base
donor
hydroxyl
amino
carboxyl
group
sever
factor
occo
dihedr
angl
pk
valu
diol
buffer
ionic
strength
well
solvent
affect
complex
small
molecul
boronolectin
sbl
drawn
great
deal
attent
carbohydr
biomark
recognit
target
sever
recent
review
research
paper
comprehens
summar
use
boron
acid
sensor
design
carbohydr
fluorid
cyanid
well
indepth
discuss
factor
consid
along
line
design
sensor
besid
also
quit
recent
review
research
paper
boron
acid
chang
fluoresc
properti
upon
bind
nucleophil
analyt
ph
chang
reader
refer
abovereferenc
paper
detail
sever
repres
exampl
discuss
highlight
applic
one
exampl
come
wang
lab
develop
anthracenebas
diboron
acid
compound
sialyl
lewi
x
sle
x
anthracenebas
boron
acid
first
develop
shinkai
group
whose
fluoresc
quench
nitrogen
lone
pair
electron
recov
lone
pair
electron
mask
proton
bind
carbohydr
take
advantag
wang
cowork
success
design
synthes
seri
anthracenebas
diboron
acid
compound
differ
linker
rigid
spatial
orient
recognit
sle
x
cell
surfac
among
design
compound
sensor
figur
stand
excel
receptor
abl
label
sle
x
express
cell
low
concentr
without
crossreact
leyexpress
cell
repres
first
exampl
small
organ
molecul
use
fluoresc
label
cell
base
cellsurfac
carbohydr
structur
develop
along
line
could
lead
number
small
molecul
boronolectin
label
drug
deliveri
select
imag
applic
anoth
exampl
hall
lab
report
orthohydroxymethyl
phenylboron
acid
scheme
compet
well
wellestablish
dialkylamino
wulfftyp
analog
better
bind
affin
solubl
signific
find
compound
weak
encourag
bind
model
glycopyranosid
aqueou
media
physiolog
ph
appar
bind
constant
methyl
determin
slightli
lower
glucos
k
system
use
hindsgaul
lab
detect
termin
glycosyl
glycoprotein
aid
color
orthohydroxymethyl
phenylboron
acid
conjug
scheme
bind
orthohydroxymethyl
phenylboron
acid
glycoconjug
anoth
area
develop
recent
carbohydr
sensor
design
nucleic
acidbas
boronolectin
nabl
wang
lab
work
incorpor
boron
acidmodifi
thymidin
dna
aptam
select
work
glycoprotein
boron
acidlabel
thymidin
triphosph
bttp
figur
success
synthes
demonstr
dna
polymeras
recogn
bttp
substrat
boron
acidlabel
dna
templat
critic
issu
aptam
select
work
one
challeng
task
carbohydr
recognit
differenti
glycosyl
pattern
glycoprotein
take
advantag
gener
aptam
select
method
develop
year
lab
szostak
joyc
gold
well
intrins
affin
boron
acid
carbohydr
reason
believ
incorpor
boron
acid
dna
aptam
would
allow
select
process
gravit
toward
glycosyl
site
therefor
allow
differenti
glycosyl
pattern
anslyn
cowork
invent
method
use
aptam
finetun
select
boron
acidbas
synthet
small
molecul
receptor
specif
organ
receptor
figur
immobil
glyoxal
agaros
bead
reduct
amin
form
immobil
receptor
complex
tartrat
target
select
control
compound
incap
bind
tartrat
use
counter
select
progress
select
monitor
incorpor
radiolabel
rna
pool
approach
author
success
select
aptam
good
select
complex
bisboron
acid
receptor
tartrat
tartrat
k
k
citrat
meoh
one
explan
select
aptam
might
form
pocket
precis
accommod
receptortartr
complex
exclud
citrat
via
steric
interact
charg
repuls
work
lead
applic
improv
specif
synthet
receptor
develop
biosensor
small
organ
analyt
addit
nucleic
acidbas
boronolectin
nabl
effort
make
peptid
boronolectin
pbl
purpos
exampl
anslyn
lab
group
develop
chemosensor
array
pbl
saccharid
saccharid
deriv
even
sucralos
real
world
beverag
sampl
good
water
solubl
high
sensit
physiolog
ph
duggan
lab
prepar
solidsupport
pbl
deriv
studi
affin
alizarin
hall
lab
develop
gener
solidphas
approach
synthesi
isol
function
boron
acid
use
combinatori
librari
synthesi
boron
acidbas
carbohydr
sensor
lavign
lab
report
pbl
sensor
glycom
recognit
potenti
cancer
diagnosi
along
similar
line
hall
cowork
also
establish
prototyp
beadsupport
splitpool
librari
triaminederiv
triboron
acid
receptor
recent
schultz
lab
success
demonstr
feasibl
ad
boron
function
genet
code
e
coli
high
yield
effici
specif
pboronophenylalanin
figur
incorpor
protein
intrins
affin
boron
acid
group
allow
select
high
affin
prbl
addit
method
potenti
use
purifyc
nativ
protein
sequenc
onestep
scarless
affin
procedur
recent
bertozzi
lab
develop
label
approach
probe
function
glycan
live
system
applic
tool
studi
glycobiolog
identif
novel
glycanbas
tumor
biomark
gener
principl
reli
avail
toolkit
azido
sugar
metabol
label
differ
class
glycan
azido
sugar
recogn
respect
processingincorpor
enzym
use
tag
via
two
bioorthogon
reaction
stauding
ligat
figur
cycloaddit
click
reaction
figur
along
line
seri
success
applic
publish
exampl
azidebear
mannaz
employ
visual
sialic
acid
live
cell
use
phosphin
cyclooctyn
reagent
strategi
develop
perform
vivo
imag
simultan
imag
express
two
differ
glycan
also
achiev
introduc
two
chemic
report
keton
azid
sialic
acid
nacetylgalactosamin
galnac
residu
allow
control
introduct
two
fluoresc
probe
monitor
glycan
express
dynam
fretbas
fluorogen
phosphin
livecel
imag
stauding
ligat
also
exploit
recent
use
huisgen
dipolar
cycloaddit
alkyn
bertozzi
lab
develop
strain
alkyn
figur
copperfre
cycloaddit
boon
lab
subsequ
also
report
strain
alkyn
copperfre
cycloaddit
azido
compound
figur
avail
alkyn
copper
free
cycloaddit
especi
import
live
cell
imag
toxic
issu
copper
live
system
techniqu
dynam
glycan
traffick
popul
sialoglycoconjug
unexpectedli
rapid
intern
kinet
studi
anoth
exampl
use
noninvas
imag
glycan
live
develop
zebrafish
experi
zebrafish
embryo
first
treat
unnatur
sugar
metabol
label
cellsurfac
glycan
azid
visual
use
vivo
cufre
click
reaction
fluorophoreconjug
bertozzi
group
also
perform
spatiotempor
analysi
glycan
express
traffick
identifi
pattern
use
multicolor
detect
strategi
conclus
carbohydr
serv
import
biolog
function
wide
varieti
process
binder
specif
recogn
carbohydr
biomark
use
site
specif
deliveri
therapeut
imag
agent
specif
recognit
carbohydr
mediat
patholog
process
potenti
use
way
develop
novel
type
therapeut
agent
recent
year
seen
tremend
amount
work
develop
carbohydr
binder
boronolectin
show
special
promis
almost
certainti
new
diagnost
therapeut
agent
come
distant
futur
reli
carbohydr
recognit
